Firmonertinib mesylate

SI-7960

Firmonertinib mesylate, >98% (HPLC)

CAS No. : [2130958-55-1]

Synonyms : Alflutinib mesylate; Furmonertinib mesylate; AST-2818 mesylate

IUPAC Name : N-(2-((2-(Dimethylamino)ethyl)(methyl)amino)-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)acrylamide methanesulfonate

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
25MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
50MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
100MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
250MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
500MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026

Applications : Firmonertinib mesylate is an orally active, brain‑penetrant EGFR inhibitor that selectively targets activating mutations and the T790M resistance mutation. Its pharmacological profile supports research applications in advanced NSCLC, including models driven by EGFR exon 20 insertions.

References : Shi Y. et al.: Journal of Thoracic Oncology, Volume 12, Issue 11, Supplement 2S2138, 2017; Spira I. A. et al.: Journal of Clinical Oncology, 42(16), TPS8668, 2024.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.